|
|
 |
Trial Information
Summary: Phase III, Double-blind, Sleep Maintenance study with Stable Diabetes Type II. Treatment is with investigational medication.
This study is for subjects that have problems staying asleep but not falling asleep and has Type II diabetes under control of oral medication. This study is outpatient with visits that vary from weekly to monthly.
Patient Inclusion Criteria:
- Able to read and speak English
- Insomnia
- Diabetes Type II
- BMI of 33
- Generally Healthy
- Age 18 and up
- Women of Child Bearing potential need to be abstinent, Surgically sterile, or using birth control method that has a less than 1% failure rate.
Patient Exclusion Criteria:
- Any other Diagnosis
- Females who are pregnant or lactating
- Consume more than 5 cups of caffeine per day
- Use of any substance with psychotropic effects or preperties known to affect sleep/wake.
- History of epilepsy or seizures
- Drug abuse
Primary Outcomes: Questionnaires and automated phone questionnaires
|
Contact:
Harry Chung, Director of Research
Behavioral Research Specialists, LLC
222 W. Eulalia Street, Suite 301
Glendale, CA 91204
Telephone: 1-818-524-0000
Fax: 1-818-255-7744
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:46:00 AM
|
 |
|